A.B. Gorde, A. Ansari and R. Ramapanicker
Tetrahedron 87 (2021) 132095
(3 ꢁ 20 mL) and dried over Na2SO4 and filtered. Solvents were
removed under reduced pressure to get the peptide catalyst (2 to 5).
(R)-N-((R)-1-phenyl-5-((trifluoromethyl)sulfonamido)pen-
Racemic mixtures of the
g
-nitro aldehydes were prepared as
references for HPLC analysis by carrying out each of the reactions
listed in Table 3 in the presence of 20 mol% of DL-proline as the
catalyst.
(2S,3R)-2-methyl-4-nitro-3-phenylbutanal
chromatography (90:10 petroleum ether/EtOAc); Pale yellow oil
(0.097 g, 94% Yield); 1H NMR (400 MHz, CDCl3)
tan-2-yl)pyrrolidine-2-carboxamide (2): White wax, (0.69 g,
25
86%); [
d
a]
¼ þ17.50 (c 0.40, MeOH); 1H NMR (400 MHz, CDCl3)
(7a):
Column
D
10.45 (d, J ¼ 3.1 Hz,1H), 7.78 (s,1H), 7.60 (s,1H), 7.54e7.33 (m, 1H),
7.27e7.20 (m, 2H), 7.15 (t, J ¼ 6.7 Hz, 2H), 4.56e4.04 (m, 3H), 3.21
(d, J ¼ 30.8 Hz, 3H), 2.87 (dd, J ¼ 13.4, 4.0 Hz, 1H), 2.61 (dd, J ¼ 12.8,
10.1 Hz, 1H), 2.23e2.06 (m, 1H), 1.93e1.75 (m, 1H), 1.61-1-40 (m,
d
9.70 (d, J ¼ 1.7 Hz,
1H), 7.32 (dd, J ¼ 9.9, 4.1 Hz, 3H), 7.18e7.14 (m, 2H), 4.78 (dd, J ¼ 6.9,
4.2 Hz, 1H), 4.67 (dd, J ¼ 12.6, 9.4 Hz, 1H), 3.80 (dd, J ¼ 9.1, 3.5 Hz,
1H), 2.81e2.74 (m, 1H), 0.99 (d, J ¼ 7.3 Hz, 3H) ppm; 13C NMR
6H) ppm; 13C NMR (100 MHz, CDCl3)
d 168.6, 137.8, 129.2, 128.4,
126.6, 119.7 (q, J ¼ 320.9 Hz), 59.6, 51.5, 46.6, 43.9, 41.4, 31.4, 30.3,
26.42, 24.3 ppm; FTIR (thin film): ῡ ¼ 3310, 3087, 2925, 1671, 1565,
1454, 1371, 1229, 1190 cmꢂ1. HRMS (ESI-TOF) m/z: [MþH]þcalcd for
(100 MHz, CDCl3) d 202.3, 136.6, 129.1, 128.2, 128.1, 78.1, 48.5, 44.1,
12.2 ppm; HRMS (ESI-TOF) m/z: [MꢂH]ꢂcalcd for C11H12NO3
206.0817, found 206.0827; HPLC (Chiralpak-IC column, Hexane:2-
C
17H25F3N3O3S 408.1569, found 408.1561.
Propanol ¼ 90:10, flow rate: 0.7 mL/min,
l
¼ 254 nm), tR
(S)-1-(L-prolyl)-N-((S)-1-phenyl-3-((trifluoromethyl)sulfona-
major ¼ 31.24, tR minor ¼ 36.42, 97% ee and dr 82:18.
mido)propan-2-yl)pyrrolidine-2-carboxamide (3): White solid
(2S,3R)-2-ethyl-4-nitro-3-phenylbutanal (7b): Column chro-
matography (90:10 petroleum ether/EtOAc); Pale yellow oil (0.10 g,
(0.74 g, 90%); [
a
]
¼ ꢂ39.02 (c 0.41, MeOH); 1H NMR (400 MHz,
25
D
CD3OD)
d
7.36e7.12 (m, 5H), 4.44 (dd, J ¼ 20.4, 5.8 Hz, 1H),
92% Yield); 1H NMR (400 MHz, CDCl3)
d
9.71 (d, J ¼ 2.6 Hz, 1H),
4.25e4.07 (m, 1H), 3.68e3.49 (m, 2H), 3.43e3.18 (m, 5H),
2.94e2.73 (m, 2H), 2.54e2.36 (m, 1H), 2.23e1.76 (m, 7H) ppm; 13
NMR (100 MHz, METHANOL-D3) 172.5, 171.7, 167.3, 167.2, 138.1,
7.35e7.28 (m, 3H), 7.17 (dd, J ¼ 5.3, 3.0 Hz, 2H), 4.71 (dd, J ¼ 12.8,
5.0 Hz, 1H), 4.62 (dd, J ¼ 12.7, 9.7 Hz, 1H), 3.81e3.75 (m, 1H),
2.68e2.65 (m, 1H), 1.52e1.46 (m, 2H), 0.82 (t, J ¼ 7.5 Hz, 3H) ppm;
C
d
137.54,128.9,128.2,126.37,126.32,120.1 (q, J ¼ 321.5 Hz), 60.6, 59.9,
58.9, 51.4, 47.1, 46.2, 46.0, 37.1, 37.0, 31.9, 29.3, 28.2, 24.5, 23.9,
21.6 ppm; FTIR (thin film): ῡ ¼ 3287,3089, 2957, 2931, 1659, 1544,
1497, 1476, 1455, 1377, 1331, 1229, 1162, 1151, cmꢂ1. HRMS (ESI-TOF)
m/z: [MþH]þcalcd for C20H28F3N4O4S 477.1783, found 477.1778.
(R)-1-(L-prolyl)-N-((S)-1-phenyl-3-((trifluoromethyl)sulfo-
13C NMR (100 MHz, CDCl3)
d 203.2, 136.8, 129.2, 128.2, 128.0, 78.6,
55.0, 42.7, 20.4, 10.7 ppm; HRMS (ESI-TOF) m/z: [MꢂH]ꢂcalcd for
C
12H14NO3 220.0974, found 220.0977; HPLC (Chiralpak-IC column,
Hexane:2-Propanol ¼ 90:10, flow rate: 0.7 mL/min,
l
¼ 254 nm), tR
major ¼ 21.83, tR minor ¼ 24.59, 97% ee and dr 92:8.
(S)-2-((R)-2-nitro-1-phenylethyl)pentanal (7c): Column chro-
namido)propan-2-yl)pyrrolidine-2-carboxamide (4): White solid
matography (90:10 petroleum ether/EtOAc); Pale yellow oil
25
(0.71 g, 87%); [
a
]
¼ þ7.87 (c 0.33, MeOH); 1H NMR (400 MHz,
(0.103 g, 88% Yield); 1H NMR (400 MHz, CDCl3)
d
9.69 (d, J ¼ 3.0 Hz,
D
CD3OD)
d
7.39e7.03 (m, 5H), 4.45e4.26 (m, 1H), 4.23e4.00 (m, 1H),
1H), 7.34e7.28 (m, 3H), 7.16 (dd, J ¼ 6.9, 1.6 Hz, 2H), 4.70e4.62 (m,
2H), 3.80e3.73 (m, 1H), 2.72e2.66 (m, 1H), 1.41e1.29 (m, 4H), 0.79
3.63 (dt, J ¼ 10.1, 7.2 Hz, 1H), 3.49e3.42 (m, 1H), 3.34e317 (m, 4H),
3.15e3.03 (m, 1H), 2.98e2.85 (m, 1H), 2.70e2.61 (m, 1H), 2.41e2.28
(m, 1H), 2.21e1.69 (m, 6H), 1.65e1.53 (m, 1H) ppm; 13C NMR
(t, J ¼ 7.1 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3)
d 203.3, 136.8,
129.2, 128.2, 128.0, 78.4, 53.8, 43.2, 29.5, 19.8, 14.0 ppm; HRMS (ESI-
TOF) m/z: [MꢂH]ꢂcalcd for C13H16NO3 234.1130, found 234.1134;
HPLC (Chiralpak-IC column, Hexane:2-Propanol ¼ 90:10, flow rate:
(100 MHz, METHANOL-D4)
d 172.3, 172.0, 169.7, 169.6, 137.9, 129.0,
128.0, 126.1, 120.7 (q, J ¼ 323.0 Hz), 60.8, 60.3, 58.9, 58.7, 51.8, 51.4,
47.0, 46.9, 46.5, 46.3, 37.8, 37.5, 29.3, 29.1, 28.5, 24.5, 24.0 ppm; FTIR
(thin film): ῡ ¼ 3285,3088, 2957, 2925, 1650, 1549, 1476, 1478, 1457,
0.8 mL/min,
l
¼ 254 nm), tR major ¼ 26.95, tR minor ¼ 31.18, 96% ee
and dr 90:10.
1417, 1374, 1280, 1165, 1156, cmꢂ1
.
HRMS (ESI-TOF) m/z:
(2S,3R)-2-isopropyl-4-nitro-3-phenylbutanal (7d): Column
chromatography (90:10 petroleum ether/EtOAc); Pale yellow oil
[MþH]þcalcd for C20H28F3N4O4S 477.1783, found 477.1771.
(S)-1-(D-prolyl)-N-((S)-1-phenyl-3-((trifluoromethyl)sulfo-
(0.10 g, 85% Yield); 1H NMR (400 MHz, CDCl3)
d
9.92 (d, J ¼ 2.4 Hz,
namido)propan-2-yl)pyrrolidine-2-carboxamide (5): White solid
1H), 7.36e7.27 (m, 3H), 7.20e7.16 (m, 2H), 4.66 (dd, J ¼ 12.4, 4.4 Hz,
1H), 4.56 (dd, J ¼ 12.4, 10.0 Hz, 1H), 3.89 (td, J ¼ 10.3, 4.4 Hz, 1H),
2.76 (ddd, J ¼ 10.6, 4.1, 2.5 Hz, 1H), 1.75e1.67 (m, 1H), 1.09 (d,
J ¼ 7.2 Hz, 3H), 0.87 (d, J ¼ 6.9 Hz, 3H) ppm; 13C NMR (100 MHz,
25
(0.70 g, 85%); [
CD3OD)
(m, 1H), 3.69e3.56 (m, 1H), 3.51e3.45 (m, 1H), 3.39e3.12 (m, 5H),
2.95e2.66 (m, 2H), 2.47e2.30 (m, 1H), 2.25e1.61 (m, 7H) ppm; 13
NMR (100 MHz, METHANOL-D3) 172.5, 172.3, 169.7, 169.5, 137.9,
a
]
¼ ꢂ12.72 (c 0.33, MeOH); H NMR (400 MHz,
D
d
7.32e7.11 (m, 5H), 4.32 (dd, J ¼ 11.2, 8.4 Hz, 1H), 4.27e4.11
C
CDCl3) d 204.4, 137.1, 129.2, 128.1, 128.0, 79.0, 58.8, 42.0, 28.0, 21.7,
d
17.0 ppm; HRMS (ESI-TOF) m/z: [MꢂH]ꢂcalcd for C13H16NO3
129.1, 128.9, 128.2, 128.0, 126.3, 121.3 (q, J ¼ 323.7 Hz), 61.6, 60.1,
59.0, 52.4, 51.6, 47.0, 46.8, 46.5, 46.1, 37.9, 37.2, 29.3, 28.4, 25.2, 24.4,
23.8 ppm; FTIR (thin film): ῡ ¼ 3290,3072, 2965, 2931, 1667, 1534,
1497, 1466, 1417, 1377, 1329, 1266, 1152 cmꢂ1. HRMS (ESI-TOF) m/z:
[MꢂH]ꢂcalcd for C20H26F3N4O4S 475.1627, found 475.1625.
234.1130, found 234.11177; HPLC (Chiralpak-IC column, Hexane:2-
Propanol ¼ 90:10, flow rate: 0.5 mL/min,
l
¼ 254 nm), tR
major ¼ 27.07, tR minor ¼ 30.72, 95% ee and dr 98:2.
(S)-2-((R)-2-nitro-1-phenylethyl)hexanal (7e): Column chro-
matography (90:10 petroleum ether/EtOAc); Pale yellow oil (0.10 g,
86% Yield); 1H NMR (400 MHz, CDCl3)
d
9.69 (d, J ¼ 2.7 Hz, 1H),
6. General procedure for the Michael addition of aldehydes to
nitroalkenes
7.37e7.28 (m, 3H), 7.16 (d, J ¼ 6.9 Hz, 2H), 4.72e4.60 (m, 2H),
3.79e3.73 (m, 1H), 2.72e2.64 (m, 1H), 1.49e1.39 (m, 2H), 1.23e1.12
(m, 4H), 0.77 (t, J ¼ 6.7 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3)
To a solution of the aldehyde (1.5 mmol, 3.0 equiv) in 2 mL of the
xylene, the nitroalkene (0.5 mmol, 1.0 equiv) and the catalyst 5
(0.007 g, 0.015 mmol, 0.03 equiv) were added and stirred at rt. The
reaction was continued until the complete disappearance of
nitroalkenes on TLC. The solvent was removed under reduced
pressure and Michael adduct were purified by column chroma-
tography. 1H NMR of crude reaction mixtures were taken to
determine the diastereomeric ratios, wherever applicable. Purified
compounds were subjected to HPLC analysis for the determination
of enantiomeric ratios.
d 203.3, 136.8, 129.1, 128.2, 128.0, 78.5, 53.9, 43.2, 28.6, 27.1, 22.5,
13.7 ppm; HRMS (ESI-TOF) m/z: [MꢂH]ꢂcalcd for C14H18NO3
248.1287, found 248.1285; HPLC (Chiralpak-IC column, Hexane:2-
Propanol ¼ 90:10, flow rate: 0.7 mL/min,
l
¼ 254 nm), tR
major ¼ 22.91, tR minor ¼ 26.63, 94% ee and dr 96:4.
(S)-2-((R)-2-nitro-1-phenylethyl)heptanal (7f): Column chro-
matography (92:8 petroleum ether/EtOAc); Pale yellow oil (0.11 g,
85% Yield); 1H NMR (400 MHz, CDCl3)
d
9.69 (d, J ¼ 2.9 Hz, 1H),
7.35e7.26 (m, 3H), 7.17e7.15 (m, 2H), 4.69 (dd, J ¼ 12.8, 5.3 Hz, 1H),
4.62 (dd, J ¼ 12.7, 9.5 Hz, 1H), 3.76 (td, J ¼ 9.6, 5.2 Hz,1H), 2.73e2.65
8